Invus Financial Advisors, LLC
- SEC CIK
- 0001802978
- Latest filing
- Aug 14, 2024
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 8
- 0 vs. Q2 2022
- Portfolio value
- $182.2M
- +$16.6M (+10.0%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CPNGCoupang, Inc. | CL A | 3,046,571 | $50.8M | 27.9% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 1,612,077 | $42.2M | 23.1% | 00.0% | Unchanged | History |
| NVCRNovoCure Ltd | ORD SHS | 350,884 | $26.7M | 14.6% | 00.0% | Unchanged | History |
| NUNu Holdings Ltd. | ORD SHS CL A | 5,582,950 | $24.6M | 13.5% | 00.0% | Unchanged | History |
| OYSTOyster Point Pharma, Inc. | COM | 2,768,586 | $15.6M | 8.5% | 00.0% | Unchanged | History |
| TBLATaboola.com Ltd. | ORD SHS | 7,819,690 | $14.2M | 7.8% | 00.0% | Unchanged | History |
| IONQIonQ, Inc. | COM | 1,000,000 | $5.07M | 2.8% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,007,575 | $3.22M | 1.8% | 00.0% | Unchanged | History |